HERGスクリーニングの世界市場レポート 2025年

HERGスクリーニング市場規模は、今後数年で急成長が見込まれます。2029年にはCAGR12.0％で29億米ドルに成長します。予測期間の成長は、個別化医療の拡大、医薬品開発活動のアウトソーシングの増加、新興国市場および研究、非心臓安全性評価への注力などに起因すると考えられます。予測期間における主な動向としては、高度なin vitroモデル、ゲノムおよびプロテオミクスデータの統合、計算アプローチの進歩、小児の医薬品安全性への注目、データ共有と標準化のための共同研究などが挙げられます。

心臓疾患患者の増加は、今後数年間のHERGスクリーニング市場の拡大を促進すると予想されます。心臓疾患は心血管疾患とも呼ばれ、心臓や血管に影響を及ぼすさまざまな疾患を包含します。これらの問題は心臓の機能を損ない、深刻な健康合併症を引き起こす可能性があります。これらの疾患の要因としては、不健康なライフスタイル、高齢化、遺伝的素因、糖尿病、メタボリックシンドロームなどが挙げられます。HERGスクリーニングは、潜在的な薬剤候補を同定し、生命を脅かす不整脈、特にTdP（Torsade de Pointes）のような心臓の有害事象のリスクを低減し、患者の転帰を向上させる上で重要な役割を果たしています。例えば、2023年5月に米国疾病予防管理センター（CDC）が発表した報告書によると、米国では20歳以上の成人の20人に1人が心血管疾患に罹患しており、これらの疾患が原因で695,000人が罹患し、375,476人が死亡していることが明らかになりました。同様に、2022年3月に発表された英国国家統計局のデータによると、心臓発作で死亡した人は20,061人で、前年より増加しています。このように、心臓疾患の有病率の増加がHERGスクリーニング市場の拡大に寄与しています。

HERGスクリーニング市場の主要企業は、医薬品開発プロセスにおける心臓安全性評価を強化するため、GLP認定HERGスクリーニングサービスなどの革新的ソリューションに積極的に注力しています。GLP認定のHERGスクリーニングでは、ICH S7AやICH S7Bなどの規制ガイドラインに準拠した、従来の全細胞パッチクランプ法を用いたヒトエーテルa-go-go関連遺伝子（hERG）のスクリーニングを行います。これらのガイドラインは、医薬品開発における安全性薬理試験にとって極めて重要です。例えば、2023年8月、英国の製薬会社Metrion Biosciences Ltd.は、GLP認定のHERGスクリーニングサービスを導入しました。このサービスは、低分子治療薬の開発をサポートし、既存の心臓安全性サービス・ポートフォリオを補完するよう設計されており、第1相臨床試験に入る前に、従来の全細胞パッチクランプ法を用いて潜在的な心臓負債を評価します。また、安全性薬理試験のための規制ガイダンスを提供し、イオンチャンネルターゲットのための高品質な生物学的サービスを提供します。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場- 金利、インフレ、地政学、コロナ、回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界HERGスクリーニング PESTEL分析（政治、社会、技術、環境、法的要因、促進要因、抑制要因）
• 最終用途産業の分析
• 世界のHERGスクリーニング市場：成長率分析
• 世界のHERGスクリーニング市場の実績：規模と成長, 2019-2024
• 世界のHERGスクリーニング市場の予測：規模と成長, 2024-2029, 2034F
• 世界HERGスクリーニング総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界のHERGスクリーニング市場：タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 遺伝子KCNH2
• 変異KCNH2
• 世界のHERGスクリーニング市場イオンチャネルによる、実績と予測, 2019-2024, 2024-2029F, 2034F
• 電圧ゲート
• リガンドゲート
• 世界のHERGスクリーニング市場：用途別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 抗不整脈薬
• 抗精神病薬
• 抗生物質
• その他の用途
• 世界のHERGスクリーニング市場、遺伝子KCNH2のサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 野生型KCNH2
• 組み換えKCNH2
• 世界のHERGスクリーニング市場、変異KCNH2のサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 突然変異
• ミスセンス変異
• ナンセンス変異
• フレームシフト変異

第7章 地域別・国別分析

• 世界のHERGスクリーニング市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界のHERGスクリーニング市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• HERGスクリーニング市場：競合情勢
• HERGスクリーニング市場：企業プロファイル
  • Eurofins-Cerep SA. Overview, Products and Services, Strategy and Financial Analysis
  • Aviva Biosciences Inc. Overview, Products and Services, Strategy and Financial Analysis
  • AstraZeneca Public Limited Company Overview, Products and Services, Strategy and Financial Analysis
  • Merck KGaA Overview, Products and Services, Strategy and Financial Analysis
  • Charles River Laboratories Inc. Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Abcam Public Limited Company
• Molecular Devices LLC
• Caliper Life Sciences Inc.
• Crprotex Limited
• ChanTest Corporation
• Creative bioarray Inc.
• Cellular Dynamics International Inc.
• Nanion Technologies
• Essen Bioscience
• ABR-Affinity BioReagents Inc.
• ACEA Biosciences Inc.
• Metrion biosciences Inc.
• Aurora Biomed Inc.
• Aureus Sciences
• RedShift BioAnalytics

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• HERGスクリーニング市場2029：新たな機会を提供する国
• HERGスクリーニング市場2029：新たな機会を提供するセグメント
• HERGスクリーニング市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Human Ether-a-go-go-related gene (HERG) screening is a crucial step in evaluating the potential cardiotoxic effects of a drug or compound. This screening process plays a vital role in preclinical safety assessment within the drug discovery and development phases, serving to guarantee the safety and effectiveness of newly developed therapeutic agents.

HERG screening encompasses two primary categories, gene KCNH2 and mutant KCNH2. The KCNH2 gene, also recognized as the human ether-a-go-go-related gene (hERG) or hERG gene, encodes the alpha subunit of a potassium ion channel pivotal in the regulation of the heart's electrical activity. This gene encompasses diverse ion channels, including both voltage-gated and ligand-gated variations. Its applications span across various therapeutic domains, including antiarrhythmics, antipsychotics, antibiotics, and others, underscoring its critical role in multiple medical contexts.

The HERG screening market research report is one of a series of new reports from The Business Research Company that provides HERG screening market statistics, including HERG screening industry global market size, regional shares, competitors with a HERG screening market share, detailed HERG screening market segments, market trends and opportunities, and any further data you may need to thrive in the HERG screening industry. This HERG screening market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The HERG screening market size has grown rapidly in recent years. It will grow from $1.62 billion in 2024 to $1.84 billion in 2025 at a compound annual growth rate (CAGR) of 13.9%. The growth in the historic period can be attributed to increasing drug development activities, regulatory requirements, increasing awareness of cardiac safety, rising incidence of cardiac disorders.

The HERG screening market size is expected to see rapid growth in the next few years. It will grow to $2.9 billion in 2029 at a compound annual growth rate (CAGR) of 12.0%. The growth in the forecast period can be attributed to expansion of personalized medicine, increasing outsourcing of drug development activities, emerging markets and research, focus on non-cardiac safety assessments. Major trends in the forecast period include advanced in vitro models, integration of genomic and proteomic data, advancements in computational approaches, focus on pediatric drug safety, collaborations for data sharing and standardization.

The increasing number of patients with heart disorders is expected to drive the expansion of the HERG screening market in the coming years. Heart disorders, also referred to as cardiovascular diseases, encompass a range of conditions affecting the heart and blood vessels. These issues can impair the heart's functionality and may result in serious health complications. Factors contributing to these disorders include unhealthy lifestyles, aging populations, genetic predispositions, diabetes, and metabolic syndrome. HERG screening plays a critical role in identifying potential drug candidates, reducing the risk of adverse cardiac events like life-threatening arrhythmias, particularly torsade de pointes (TdP), and enhancing patient outcomes. For example, a report by the Centers for Disease Control and Prevention (CDC) in May 2023 revealed that 1 in 20 adults aged 20 and above in the United States have cardiovascular diseases, with 695,000 people affected and 375,476 deaths due to these conditions. Similarly, data from the Office for National Statistics in the UK, published in March 2022, indicated that 20,061 people died of heart attacks, an increase from the previous year. Thus, the growing prevalence of heart disorders is contributing to the expanding HERG screening market.

Key companies in the HERG screening market are actively focusing on innovative solutions, including GLP-certified HERG screening services, to enhance cardiac safety assessments during drug development processes. GLP-certified HERG screening involves screening the human ether-a-go-go related gene (hERG) using the conventional whole-cell patch-clamp technique, ensuring compliance with regulatory guidelines such as ICH S7A and ICH S7B. These guidelines are critical for safety pharmacology studies in drug development. For example, in August 2023, Metrion Biosciences Ltd., a UK-based pharmaceutical company, introduced the GLP-certified hERG screening service. This service is designed to support small-molecule therapeutic development, complement the existing cardiac safety service portfolio, and employ the conventional whole-cell patch-clamp technique to assess potential cardiac liabilities before entering Phase 1 clinical trials. It provides regulatory guidance for safety pharmacology studies and offers high-quality biology services for ion channel targets.

In January 2022, the Tox21 research program was established through a partnership among several US-based agencies, including the National Toxicology Program, the Environmental Protection Agency, the National Center for Advancing Translational Science, and the Food and Drug Administration. This collaboration aims to enhance the methods used for chemical toxicity testing. The agencies work together to rapidly and efficiently assess the safety of various chemicals, including those found in everyday products. Specifically for HERG screening, their objective is to analyze the molecular mechanisms of these chemicals, prioritize those requiring further investigation, and develop predictive models to evaluate their effects on living organisms.

Major companies operating in the HERG screening market are Eurofins-Cerep SA., Aviva Biosciences Inc., AstraZeneca Public Limited Company, Merck KGaA, Charles River Laboratories Inc., Abcam Public Limited Company, Molecular Devices LLC, Caliper Life Sciences Inc., Crprotex Limited, ChanTest Corporation, Creative bioarray Inc., Cellular Dynamics International Inc., Nanion Technologies, Essen Bioscience, ABR-Affinity BioReagents Inc., ACEA Biosciences Inc., Metrion biosciences Inc., Aurora Biomed Inc., Aureus Sciences, RedShift BioAnalytics, B'SYS GmbH, Cambridge Bioscience Ltd., Sophion Bioscience Inc., Fluxion Biosciences Inc., ChemAxon Ltd.

North America was the largest region in the HERG screening market in 2024. Asia-Pacific is expected to be the fastest growing region in the forecast period. The regions covered in the herg screening market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the herg screening market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The HERG screening market includes revenues earned by entities by providing services such as in vitro HERG assays, patch clamp electrophysiology, data analysis and interpretation, consultation and regulatory support, and customized assay development. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

HERG Screening Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on herg screening market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for herg screening ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The herg screening market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Type: Gene KCNH2; Mutant KCNH2
• 2) By Ion Channel: Voltage-Gated; Ligand Gated
• 3) By Applications: Antiarrhythmic; Antipsychotic; Antibiotics; Other Applications
• Subsegmeents:
• 1) By Gene KCNH2: Wild-Type KCNH2; Recombinant KCNH2
• 2) By Mutant KCNH2: Mutations: Missense Mutations; Nonsense Mutations; Frameshift Mutations
• Companies Mentioned: Eurofins-Cerep SA.; Aviva Biosciences Inc.; AstraZeneca Public Limited Company; Merck KGaA; Charles River Laboratories Inc.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. HERG Screening Market Characteristics

3. HERG Screening Market Trends And Strategies

4. HERG Screening Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global HERG Screening Growth Analysis And Strategic Analysis Framework

• 5.1. Global HERG Screening PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global HERG Screening Market Growth Rate Analysis
• 5.4. Global HERG Screening Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global HERG Screening Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global HERG Screening Total Addressable Market (TAM)

6. HERG Screening Market Segmentation

• 6.1. Global HERG Screening Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Gene KCNH2
• Mutant KCNH2
• 6.2. Global HERG Screening Market, Segmentation By Ion Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Voltage-Gated
• Ligand Gated
• 6.3. Global HERG Screening Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Antiarrhythmic
• Antipsychotic
• Antibiotics
• Other Applications
• 6.4. Global HERG Screening Market, Sub-Segmentation Of Gene KCNH2, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Wild-Type KCNH2
• Recombinant KCNH2
• 6.5. Global HERG Screening Market, Sub-Segmentation Of Mutant KCNH2, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Mutations
• Missense Mutations
• Nonsense Mutations
• Frameshift Mutations

7. HERG Screening Market Regional And Country Analysis

• 7.1. Global HERG Screening Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global HERG Screening Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific HERG Screening Market

• 8.1. Asia-Pacific HERG Screening Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific HERG Screening Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific HERG Screening Market, Segmentation By Ion Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific HERG Screening Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China HERG Screening Market

• 9.1. China HERG Screening Market Overview
• 9.2. China HERG Screening Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China HERG Screening Market, Segmentation By Ion Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China HERG Screening Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India HERG Screening Market

• 10.1. India HERG Screening Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India HERG Screening Market, Segmentation By Ion Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India HERG Screening Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan HERG Screening Market

• 11.1. Japan HERG Screening Market Overview
• 11.2. Japan HERG Screening Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan HERG Screening Market, Segmentation By Ion Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan HERG Screening Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia HERG Screening Market

• 12.1. Australia HERG Screening Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia HERG Screening Market, Segmentation By Ion Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia HERG Screening Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia HERG Screening Market

• 13.1. Indonesia HERG Screening Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia HERG Screening Market, Segmentation By Ion Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia HERG Screening Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea HERG Screening Market

• 14.1. South Korea HERG Screening Market Overview
• 14.2. South Korea HERG Screening Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea HERG Screening Market, Segmentation By Ion Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea HERG Screening Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe HERG Screening Market

• 15.1. Western Europe HERG Screening Market Overview
• 15.2. Western Europe HERG Screening Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe HERG Screening Market, Segmentation By Ion Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe HERG Screening Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK HERG Screening Market

• 16.1. UK HERG Screening Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK HERG Screening Market, Segmentation By Ion Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK HERG Screening Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany HERG Screening Market

• 17.1. Germany HERG Screening Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany HERG Screening Market, Segmentation By Ion Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany HERG Screening Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France HERG Screening Market

• 18.1. France HERG Screening Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France HERG Screening Market, Segmentation By Ion Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France HERG Screening Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy HERG Screening Market

• 19.1. Italy HERG Screening Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy HERG Screening Market, Segmentation By Ion Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy HERG Screening Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain HERG Screening Market

• 20.1. Spain HERG Screening Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain HERG Screening Market, Segmentation By Ion Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain HERG Screening Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe HERG Screening Market

• 21.1. Eastern Europe HERG Screening Market Overview
• 21.2. Eastern Europe HERG Screening Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe HERG Screening Market, Segmentation By Ion Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe HERG Screening Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia HERG Screening Market

• 22.1. Russia HERG Screening Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia HERG Screening Market, Segmentation By Ion Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia HERG Screening Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America HERG Screening Market

• 23.1. North America HERG Screening Market Overview
• 23.2. North America HERG Screening Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America HERG Screening Market, Segmentation By Ion Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America HERG Screening Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA HERG Screening Market

• 24.1. USA HERG Screening Market Overview
• 24.2. USA HERG Screening Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA HERG Screening Market, Segmentation By Ion Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA HERG Screening Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada HERG Screening Market

• 25.1. Canada HERG Screening Market Overview
• 25.2. Canada HERG Screening Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada HERG Screening Market, Segmentation By Ion Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada HERG Screening Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America HERG Screening Market

• 26.1. South America HERG Screening Market Overview
• 26.2. South America HERG Screening Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America HERG Screening Market, Segmentation By Ion Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America HERG Screening Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil HERG Screening Market

• 27.1. Brazil HERG Screening Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil HERG Screening Market, Segmentation By Ion Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil HERG Screening Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East HERG Screening Market

• 28.1. Middle East HERG Screening Market Overview
• 28.2. Middle East HERG Screening Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East HERG Screening Market, Segmentation By Ion Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East HERG Screening Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa HERG Screening Market

• 29.1. Africa HERG Screening Market Overview
• 29.2. Africa HERG Screening Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa HERG Screening Market, Segmentation By Ion Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa HERG Screening Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. HERG Screening Market Competitive Landscape And Company Profiles

• 30.1. HERG Screening Market Competitive Landscape
• 30.2. HERG Screening Market Company Profiles
  • 30.2.1. Eurofins-Cerep SA. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Aviva Biosciences Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. AstraZeneca Public Limited Company Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Merck KGaA Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Charles River Laboratories Inc. Overview, Products and Services, Strategy and Financial Analysis

31. HERG Screening Market Other Major And Innovative Companies

• 31.1. Abcam Public Limited Company
• 31.2. Molecular Devices LLC
• 31.3. Caliper Life Sciences Inc.
• 31.4. Crprotex Limited
• 31.5. ChanTest Corporation
• 31.6. Creative bioarray Inc.
• 31.7. Cellular Dynamics International Inc.
• 31.8. Nanion Technologies
• 31.9. Essen Bioscience
• 31.10. ABR-Affinity BioReagents Inc.
• 31.11. ACEA Biosciences Inc.
• 31.12. Metrion biosciences Inc.
• 31.13. Aurora Biomed Inc.
• 31.14. Aureus Sciences
• 31.15. RedShift BioAnalytics

32. Global HERG Screening Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The HERG Screening Market

34. Recent Developments In The HERG Screening Market

35. HERG Screening Market High Potential Countries, Segments and Strategies

• 35.1 HERG Screening Market In 2029 - Countries Offering Most New Opportunities
• 35.2 HERG Screening Market In 2029 - Segments Offering Most New Opportunities
• 35.3 HERG Screening Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer